1 citations
,
January 2015 in “Hair therapy & transplantation”
The authors argue that despite the growing popularity of hair transplantation for aesthetic reasons, many patients often experience disappointment and frustration after multiple procedures.
1 citations
,
January 2017 in “International Journal of Dermoscopy”
This study observed that dermoscopy is a valuable tool for hair transplant surgeons to evaluate and improve the aesthetic outcomes and address technical errors in transplant procedures.
July 2022 in “International Journal of Health Sciences”
This review discusses various long-term complications among COVID-19 survivors, reporting no new clinical results, and underlines the need for vigilant monitoring by healthcare providers.
This study found that male patients with systemic lupus erythematosus had a higher prevalence of certain complications like thromboses and nephropathy than female patients, suggesting gender influences the disease's clinical expression.
This article discusses how medicinal plants, known for their antiviral, immunomodulatory, antioxidant, and anti-inflammatory properties, may help alleviate long-term COVID-19 effects, but emphasizes the need for further clinical trials to confirm safety and efficacy.
A Korean laser helmet increases hair growth by 44% compared to a placebo. Users discuss its cost-effectiveness, clinical support, and compare it to treatments like finasteride and minoxidil, focusing on wavelength and energy density.
A user shared their experience with a Long Hair DHI Hair Transplant, receiving 2,750 grafts. They plan to continue using Dutasteride and Topical Minoxidil post-surgery.
The conversation discusses using finasteride, dutasteride, minoxidil, cialis, and metformin to protect hair and health. Some users caution against self-prescribing these drugs due to potential risks and complications.
People are seeking updates on PP405, a hair loss treatment, with no new information available beyond old news and speculation about trial phases. A user shared concerns about hair shedding after using finasteride and minoxidil, with others suggesting it might be temporary shedding.
A user is advocating for Phase 3 trials of the hair loss treatment PP405 to be conducted in Germany, citing benefits like a diverse patient base and faster access for European patients. Despite skepticism about the petition's influence, the user believes it can demonstrate significant interest and potentially influence strategic decisions.